miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression

Sheng,Weizhong; Chen,Yusheng; Gong,Yuda; Dong,Tiangeng; Zhang,Bo; Gao,Weidong

doi:10.3892/or.2016.5203

miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression

Authors:
- Weizhong Sheng
- Yusheng Chen
- Yuda Gong
- Tiangeng Dong
- Bo Zhang
- Weidong Gao
View Affiliations

Affiliations: Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, P.R. China
Published online on: October 25, 2016 https://doi.org/10.3892/or.2016.5203
Pages: 3387-3396

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Anaplastic thyroid carcinoma (ATC) is aggressive and lethal with extrathyroidal invasion, distant metastasis, and resistance to conventional therapies. Cancer stem cells (CSCs) are proposed to be responsible for high recurrence rate in ATC. MicroRNAs (miRNAs) have recently been found as an important class of cellular regulators of ATC carcinogenesis. Identification of CSC-related miRNAs and targets is therefore a priority for the development of new therapeutic paradigms. Patient-derived ATC cells were cultured in conditional media on poly-hema-treated dish. ATC CSCs were isolated and enriched through as a series of steps including initial isolation of sphere-forming CSC population, subsequent amplification of this CSC population in a xenograft model treated with cisplatin, and purification of CSCs from xenograft tumors followed by final enrichment using sphere-forming assays. Expression of CSC markers was measured by flow cytometry, immunofluorescence staining, qPCR and western blot analyses. Expression of miRNAs in ATC-CSCs was profiled by microarray analysis. Proliferation and differentiation rates were determined based on the size of spheres formed in vitro and tumors formed in vivo. We successfully isolated and enriched an ATC-CSC population. We identified 17 miRNAs differentially expressed in primary ATC cells vs. ATC-CSCs, among which miRNA-148a was significantly downregulated in ATC-CSCs. Overexpression of miRNA148a in ATC-CSCs induced cell cycle arrest and loss of stem cell characteristics. In addition, we identified INO80 as a target gene of miR-148a. The expression of INO80 was upregulated in ATC-CSCs and downregulated upon miRNA-148 overexpression. Overexpression of miRNA-148a and knockdown of INO80 acted synergistically to decrease the expression of stem cell marker genes as well as to attenuate stem cell-specific properties including the ability to form tumors. This study identified novel contrasting roles for miR-148a and INO80 in the regulation of the stemness of ATC-CSCs and their capacity to initiate tumor formation. Our findings may open a new avenue for therapeutic development against ATC that targets INO80 in the CSCs through enhancing miRNA-148a levels.

View Figures

View References

1	Shaha AR: Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Laryngoscope. 114:393–402. 2004. View Article : Google Scholar : PubMed/NCBI
2	Kondo T, Ezzat S and Asa SL: Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer. 6:292–306. 2006. View Article : Google Scholar : PubMed/NCBI
3	Derwahl M: Linking stem cells to thyroid cancer. J Clin Endocrinol Metab. 96:610–613. 2011. View Article : Google Scholar : PubMed/NCBI
4	Organista-Nava J, Gómez-Gómez Y and Gariglio P: Embryonic stem cell-specific signature in cervical cancer. Tumour Biol. 35:1727–1738. 2014. View Article : Google Scholar : PubMed/NCBI
5	Kim CF and Dirks PB: Cancer and stem cell biology: How tightly intertwined? Cell Stem Cell. 3:147–150. 2008. View Article : Google Scholar : PubMed/NCBI
6	Wang Y and Armstrong SA: Cancer: Inappropriate expression of stem cell programs? Cell Stem Cell. 2:297–299. 2008. View Article : Google Scholar : PubMed/NCBI
7	Gu W, Yeo E, McMillan N and Yu C: Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability. Cancer Gene Ther. 18:897–905. 2011. View Article : Google Scholar : PubMed/NCBI
8	Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
9	Collins AT, Berry PA, Hyde C, Stower MJ and Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
10	Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
11	O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 445:106–110. 2007. View Article : Google Scholar : PubMed/NCBI
12	Schatton T, Murphy GF, Frank NY, Yamaura K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM, Weishaupt C, et al: Identification of cells initiating human melanomas. Nature. 451:345–349. 2008. View Article : Google Scholar : PubMed/NCBI
13	Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature. 432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
14	Friedman S, Lu M, Schultz A, Thomas D and Lin RY: CD133⁺ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PLoS One. 4:e53952009. View Article : Google Scholar : PubMed/NCBI
15	Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato M, et al: In vitro identification and characterization of CD133 (pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. PLoS One. 3:e35442008. View Article : Google Scholar : PubMed/NCBI
16	Todaro M, Iovino F, Eterno V, Cammareri P, Gambara G, Espina V, Gulotta G, Dieli F, Giordano S, De Maria R, et al: Tumorigenic and metastatic activity of human thyroid cancer stem cells. Cancer Res. 70:8874–8885. 2010. View Article : Google Scholar : PubMed/NCBI
17	Kreso A and Dick JE: Evolution of the cancer stem cell model. Cell Stem Cell. 14:275–291. 2014. View Article : Google Scholar : PubMed/NCBI
18	Yang ZJ and Wechsler-Reya RJ: Hit ‘em where they live: Targeting the cancer stem cell niche. Cancer Cell. 11:3–5. 2007. View Article : Google Scholar : PubMed/NCBI
19	Wang Q, Liu H, Xiong H, Liu Z, Wang LE, Qian J, Muddasani R, Lu V, Tan D, Ajani JA, et al: Polymorphisms at the microRNA binding-site of the stem cell marker gene CD133 modify susceptibility to and survival of gastric cancer. Mol Carcinog. 54:449–458. 2015. View Article : Google Scholar : PubMed/NCBI
20	Wei XD, He J, Gao JX, Wang JY, Ma BJ and Chen J: Investigation on biological characteristics of CD133⁺ cancer stem cells in human laryngeal carcinoma Hep-2 cell line. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 48:578–583. 2013.(In Chinese). PubMed/NCBI
21	Fan X, Chen X, Deng W, Zhong G, Cai Q and Lin T: Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression. BMC Cancer. 13:612013. View Article : Google Scholar : PubMed/NCBI
22	Bu P, Chen KY, Chen JH, Wang L, Walters J, Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, et al: A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. Cell Stem Cell. 12:602–615. 2013. View Article : Google Scholar : PubMed/NCBI
23	Zhang J, Luo N, Luo Y, Peng Z, Zhang T and Li S: microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol. 40:747–756. 2012.PubMed/NCBI
24	Cheng Q, Zhang X, Xu X and Lu X: MiR-618 inhibits anaplastic thyroid cancer by repressing XIAP in one ATC cell line. Ann Endocrinol (Paris). 75:187–193. 2014. View Article : Google Scholar : PubMed/NCBI
25	Xiong Y, Zhang L and Kebebew E: MiR-20a is upregulated in anaplastic thyroid cancer and targets LIMK1. PLoS One. 9:e961032014. View Article : Google Scholar : PubMed/NCBI
26	Zhang Y, Yang WQ, Zhu H, Qian YY, Zhou L, Ren YJ, Ren XC, Zhang L, Liu XP, Liu CG, et al: Regulation of autophagy by miR-30d impacts sensitivity of anaplastic thyroid carcinoma to cisplatin. Biochem Pharmacol. 87:562–570. 2014. View Article : Google Scholar : PubMed/NCBI
27	Pan L, Huang S, He R, Rong M, Dang Y and Chen G: Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues. Eur J Med Res. 19:682014. View Article : Google Scholar : PubMed/NCBI
28	Xia J, Guo X, Yan J and Deng K: The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol. 140:1451–1456. 2014. View Article : Google Scholar : PubMed/NCBI
29	Liffers ST, Munding JB, Vogt M, Kuhlmann JD, Verdoodt B, Nambiar S, Maghnouj A, Mirmohammadsadegh A, Hahn SA and Tannapfel A: MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab Invest. 91:1472–1479. 2011. View Article : Google Scholar : PubMed/NCBI
30	Zhang H, Li Y, Huang Q, Ren X, Hu H, Sheng H and Lai M: MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ. 18:1702–1710. 2011. View Article : Google Scholar : PubMed/NCBI
31	Shen X, Mizuguchi G, Hamiche A and Wu C: A chromatin remodelling complex involved in transcription and DNA processing. Nature. 406:541–544. 2000. View Article : Google Scholar : PubMed/NCBI
32	Papamichos-Chronakis M, Watanabe S, Rando OJ and Peterson CL: Global regulation of H2A.Z localization by the INO80 chromatin-remodeling enzyme is essential for genome integrity. Cell. 144:200–213. 2011. View Article : Google Scholar : PubMed/NCBI
33	Chia NY, Chan YS, Feng B, Lu X, Orlov YL, Moreau D, Kumar P, Yang L, Jiang J, Lau MS, et al: A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature. 468:316–320. 2010. View Article : Google Scholar : PubMed/NCBI
34	Hu G, Kim J, Xu Q, Leng Y, Orkin SH and Elledge SJ: A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev. 23:837–848. 2009. View Article : Google Scholar : PubMed/NCBI
35	Conaway RC and Conaway JW: The INO80 chromatin remodeling complex in transcription, replication and repair. Trends Biochem Sci. 34:71–77. 2009. View Article : Google Scholar : PubMed/NCBI
36	Morrison AJ and Shen X: Chromatin remodelling beyond transcription: The INO80 and SWR1 complexes. Nat Rev Mol Cell Biol. 10:373–384. 2009. View Article : Google Scholar : PubMed/NCBI
37	Watanabe S and Peterson CL: The INO80 family of chromatin-remodeling enzymes: Regulators of histone variant dynamics. Cold Spring Harb Symp Quant Biol. 75:35–42. 2010. View Article : Google Scholar : PubMed/NCBI
38	Wang L, Du Y, Ward JM, Shimbo T, Lackford B, Zheng X, Miao YL, Zhou B, Han L, Fargo DC, et al: INO80 facilitates pluripotency gene activation in embryonic stem cell self-renewal, reprogramming, and blastocyst development. Cell Stem Cell. 14:575–591. 2014. View Article : Google Scholar : PubMed/NCBI